Clinical Trial Update: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment [NA]

View source ↗

Summary

This clinical trial update notes completion of studies in Non-Hodgkin lymphoma patients treated with an antibody therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Antibody therapy

Snippet

Sponsor: Stanford University | Conditions: Lymphoma, Non-Hodgkin, Lymphomas: Non-Hodgkin | NA | Status: COMPLETED